Haemonetics Corp (FRA:HAZ)
€ 79 1 (1.28%) Market Cap: 3.99 Bil Enterprise Value: 4.87 Bil PE Ratio: 33.69 PB Ratio: 4.65 GF Score: 28/100

Q3 2020 Haemonetics Corp Earnings Call Transcript

Feb 04, 2020 / 01:00PM GMT
Release Date Price: €108 (+11.34%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Haemonetics Third Quarter Fiscal Year 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Olga Guyette, Investor Relations. Thank you. Please go ahead, ma'am.

Olga Guyette
Haemonetics Corporation - Senior Manager of IR

Good morning. Thank you for joining us for Haemonetics' Third Quarter Fiscal Year '20 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; and Bill Burke, our CFO.

Today, we will discuss our third quarter and year-to-date fiscal '20 results. All revenue growth rates are on an organic basis and exclude impacts from currency, product end-of-life decisions and divestitures. Our remarks today will include forward-looking statements, and our actual results may differ materially from anticipated results. Information concerning factors that could cause results to differ is available in the Form 8

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot